Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3138367
Max Phase: Preclinical
Molecular Formula: C32H50N2O4S
Molecular Weight: 558.83
Molecule Type: Small molecule
Associated Items:
ID: ALA3138367
Max Phase: Preclinical
Molecular Formula: C32H50N2O4S
Molecular Weight: 558.83
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](CCC(=O)NCCc1ccc(S(N)(=O)=O)cc1)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
Standard InChI: InChI=1S/C32H50N2O4S/c1-21(4-13-30(36)34-19-16-22-5-8-25(9-6-22)39(33,37)38)27-11-12-28-26-10-7-23-20-24(35)14-17-31(23,2)29(26)15-18-32(27,28)3/h5-6,8-9,21,23-24,26-29,35H,4,7,10-20H2,1-3H3,(H,34,36)(H2,33,37,38)/t21-,23-,24-,26+,27-,28+,29+,31+,32-/m1/s1
Standard InChI Key: OISORDIFGRDRHB-RAFSUCORSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 558.83 | Molecular Weight (Monoisotopic): 558.3491 | AlogP: 5.43 | #Rotatable Bonds: 8 |
Polar Surface Area: 109.49 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.22 | CX Basic pKa: | CX LogP: 5.06 | CX LogD: 5.06 |
Aromatic Rings: 1 | Heavy Atoms: 39 | QED Weighted: 0.40 | Np Likeness Score: 0.97 |
1. Scozzafava A, Supuran CT.. (2002) Carbonic anhydrase inhibitors. Preparation of potent sulfonamides inhibitors incorporating bile acid tails., 12 (12): [PMID:12039560] [10.1016/s0960-894x(02)00252-4] |
Source(1):